Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
SRX Global signed a stock purchase agreement to acquire CERo Therapeutics from CERo Therapeutics Holdings, issuing $1.0 million of its common stock at closing, forgiving/canceling an $8.25 million senior secured note plus accrued amounts, and assuming about $1.56 million of liabilities.
SRX Global will buy all shares of CERo Therapeutics, paying $1 million in SRX common stock priced off the lower of the prior close or 20-day VWAP and cancelling a Consolidated Senior Secured Promissory Note up to $11,666,108.77; outstanding principal was $8,249,643.77. Assumed liabilities are about $1.56 million, and S